Hikma Pharmaceuticals Aktie
23,60
EUR
±0,00
EUR
±0,00
%
20,20
GBP
+0,14
GBP
+0,70
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung